Tag: pharma admet testing industry research

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Projected Growth Rate of the Pharma ADMET Testing Market from 2024 to 2033?

The admet testing market within the pharmaceutical sector has experienced quick expansion in the last few years. Projected to launch from a value of $8.62 billion in 2023 and reach $9.61 billion in 2024, this market is expected to exhibit a compound annual growth rate (CAGR) of 11.5%. Factors contributing to the high growth rate during the historic period include the rise in biopharmaceuticals and biosimilars, an increase in drug development activities, better understanding of drug safety, the international expansion of clinical trials, and a move towards in silico modeling.

The market size of pharma admet testing is projected to experience significant expansion in the coming years, with an estimated value of $14.87 billion in 2028, exhibiting a compound annual growth rate (CAGR) of 11.5%. Factors such as environmental toxicology and safety assessments, increased knowledge of pharmacogenomics, emphasis on precision medicine, expansion of biologics and biosimilars, use of artificial intelligence (AI), intensified regulatory requirements, and the rise in the development of orphan drugs are contributing to the forecasted growth. Trending patterns in the anticipated period include accelerated research collaborations, swift tech innovations, strides in analytical technologies, ongoing drug safety monitoring, and considerations of environmental impact.

Claim Your Free Sample of the Global Pharma ADMET Testing Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp

What Are the Key Drivers of Growth in the pharma admet testing Market?

The pharma ADMET testing market is being propelled by an increasing number of product approvals. These approvals are essentially the mechanisms through which regulatory bodies like the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) gives the green light for a product to be offered and sold to consumers. It is crucial to do ADMET testing to ascertain the safety and effectiveness of new products and it is a compulsory task in the product regulatory approbation process. For example, data from the Center for Drug Evaluation and Research, a government agency in the US, reveals that 53 drugs were given approval in 2020; this is a rise compared to the 48 drugs given approval in 2019. Consequently, the growing quantity of product approvals is fuelling the pharma ADMET testing market.

What Are the Notable Segments in the Pharma ADMET Testing Market?

1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing

2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology

3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

Which Emerging Trends Are Altering the Pharma ADMET Testing Market?

The introduction of innovative products is the predominant trend emerging in the pharma ADMET testing market. Major players in this sector, such as Charles River Laboratories International Inc. and Valo Health Inc., are leveraging this trend to solidify their market dominance by launching revolutionary products like Logica. For instance, in April 2022, these US-based companies rolled out Logica, an AI-powered drug development tool. This innovative solution utilizes the Artificial Intelligence technology of Valo’s Opal Computational Platform to offer users ADMET testing services and various drug delivery solutions. Logica takes advantage of best-in-class predictive models, chemical design and synthesis capabilities, DNA-encoded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform. Additionally, it utilizes Charles River’s top-tier capabilities in all areas of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, safety testing, and ultimately IND submission.

Order Now for Fast Delivery of Your Pharma ADMET Testing Market Report!

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Which Regions Are Most Influential in Expanding the Pharma ADMET Testing Market?

Asia-Pacific was the largest region in the pharma ADMET testing market in 2023. The regions covered in the pharma admet testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Pharma ADMET Testing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the pharma admet testing market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Pharma ADMET Testing Market Include

1. Pharma ADMET Testing Market Executive Summary

2. Pharma ADMET Testing Market Segments

3. Pharma ADMET Testing Market Size And Template Market Growth Rate

4. Key Pharma ADMET Testing Market Trends

5. Major Pharma ADMET Testing Market Drivers

……

25. Key Mergers And Acquisitions In The Pharma ADMET Testing Market

26. Top Pharma ADMET Testing Companies

27. Pharma ADMET Testing Market Opportunities And Strategies

28. Pharma ADMET Testing Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Pharmacogenomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Pharmacies and Healthcare Stores Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmacies-and-healthcare-stores-global-market-report

Temperature Controlled Pharmaceutical Containers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/temperature-controlled-pharmaceutical-containers-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The pharma ADMET testing market has experienced significant growth in recent years, with notable projections for the future. Here’s a breakdown of the key factors influencing this growth trajectory:

Market Expansion in Recent Years

• The market size surged from $8.62 billion in 2023 to $9.61 billion in 2024, exhibiting a compound annual growth rate (CAGR) of 11.5%.
• Growth in the historic period is attributed to factors like the rise in biopharmaceuticals, increased drug development activities, and a global shift towards in silico modeling.

Anticipated Growth by 2028

• Forecasts indicate a further surge, with the market expected to reach $14.87 billion in 2028, maintaining the same CAGR of 11.5%.
• The forecasted period will witness growth driven by environmental toxicology, emphasis on pharmacogenomics, and the burgeoning focus on precision medicine.

Emerging Trends and Factors Shaping the Market

• Collaborative research efforts are on the rise, leading to rapid technological innovations and advancements in analytical technologies.
• Continuous monitoring of drug safety and environmental impact considerations are becoming integral aspects of ADMET testing processes.

The Impact of Increasing Product Approvals

• The rising number of product approvals is a significant driver for the pharma ADMET testing market.
• Regulatory bodies like the FDA and EMA play crucial roles in granting approvals, necessitating thorough ADMET testing for product safety and efficacy.

Key Players and Market Dynamics

• Major companies driving the pharma ADMET testing market include Thermo Fisher Scientific Inc., Abbott Laboratories, and The Merck Group, among others.
• These companies provide a range of ADMET testing services essential for regulatory compliance and product development.

View More On The Pharma ADMET Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Product Innovations Driving Market Evolution

• Product innovation is a prominent trend within the pharma ADMET testing market, with companies introducing cutting-edge solutions to stay competitive.
• Notable innovations include Logica, an AI-based drug development solution launched by Charles River Laboratories International Inc. and Valo Health Inc.

Market Expansion Through Acquisition

• BioIVT’s acquisition of XenoTech underscores the market’s expansion strategies, aiming to broaden product portfolios and reach newer geographies.
• XenoTech’s ADMET testing services complement BioIVT’s offerings, strengthening its position in the market.

Segmentation and Regional Insights

• The pharma ADMET testing market is segmented by testing type, technology, and application, catering to diverse industry needs.
• Asia-Pacific emerged as the largest region in the pharma ADMET testing market in 2023, highlighting the global nature of this industry.

Conclusion

The pharma ADMET testing market is on a robust growth trajectory, fueled by a convergence of factors such as technological innovations, regulatory dynamics, and market expansion strategies. As the industry continues to evolve, stakeholders must remain agile to harness emerging opportunities and address evolving challenges effectively. With innovation at its core, the future of ADMET testing promises advancements that will redefine drug development processes and enhance patient outcomes on a global scale.

Request A Sample Of The Global Pharma ADMET Testing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=12024&type=smp